Clinical Trials Browser

Phase 2 × OTHER × Technetium Tc 99m Medronate × Clear all

NCT05924672 2026-01-14

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT00375830 2023-12-12

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

Phase 2 Completed

114 enrolled 19 charts

Neoplasms